GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Creative Medical Technology Holdings Inc (NAS:CELZ) » Definitions » Cyclically Adjusted PS Ratio

Creative Medical Technology Holdings (Creative Medical Technology Holdings) Cyclically Adjusted PS Ratio : 0.06 (As of Apr. 28, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Creative Medical Technology Holdings Cyclically Adjusted PS Ratio?

As of today (2024-04-28), Creative Medical Technology Holdings's current share price is $4.32. Creative Medical Technology Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $70.12. Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio for today is 0.06.

The historical rank and industry rank for Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:

CELZ' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.05   Med: 0.91   Max: 553.75
Current: 0.06

During the past years, Creative Medical Technology Holdings's highest Cyclically Adjusted PS Ratio was 553.75. The lowest was 0.05. And the median was 0.91.

CELZ's Cyclically Adjusted PS Ratio is ranked better than
97.43% of 505 companies
in the Biotechnology industry
Industry Median: 5.24 vs CELZ: 0.06

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Creative Medical Technology Holdings's adjusted revenue per share data for the three months ended in Dec. 2023 was $0.002. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $70.12 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Creative Medical Technology Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings Cyclically Adjusted PS Ratio Chart

Creative Medical Technology Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.65 1.45 0.26 0.05 0.07

Creative Medical Technology Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 - - 0.07 0.07

Competitive Comparison of Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio falls into.



Creative Medical Technology Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=4.32/70.12
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creative Medical Technology Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Creative Medical Technology Holdings's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.002/129.4194*129.4194
=0.002

Current CPI (Dec. 2023) = 129.4194.

Creative Medical Technology Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.000 99.695 0.000
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 0.000 102.862 0.000
201706 0.000 103.349 0.000
201709 0.000 104.136 0.000
201712 35.714 104.011 44.438
201803 10.000 105.290 12.292
201806 5.000 106.317 6.086
201809 52.000 106.507 63.187
201812 58.000 105.998 70.816
201903 51.000 107.251 61.542
201906 62.000 108.070 74.249
201909 29.000 108.329 34.646
201912 -1.000 108.420 -1.194
202003 0.271 108.902 0.322
202006 0.824 108.767 0.980
202009 0.282 109.815 0.332
202012 0.117 109.897 0.138
202103 0.000 111.754 0.000
202106 0.043 114.631 0.049
202109 0.041 115.734 0.046
202112 0.107 117.630 0.118
202203 0.023 121.301 0.025
202206 0.000 125.017 0.000
202209 0.039 125.227 0.040
202212 0.013 125.222 0.013
202303 0.000 127.348 0.000
202306 0.000 128.729 0.000
202309 0.004 129.860 0.004
202312 0.002 129.419 0.002

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Creative Medical Technology Holdings  (NAS:CELZ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Creative Medical Technology Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Creative Medical Technology Holdings (Creative Medical Technology Holdings) Business Description

Traded in Other Exchanges
N/A
Address
211 E Osborn Road, Phoenix, AZ, USA, 85012
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Executives
Timothy Warbington director, 10 percent owner, officer: President & CEO 211 E. OSBORN ROAD, PHOENIX AZ 85012
Michael H. Finger director 1551 N. DIANE ST., MESA AZ 85203-3850
Susan H Snow director 26 SEDGE FERN DRIVE, HILTON HEAD SC 29926
Bruce Steven Urdang director 5171 E. HAWTHORNE DR., FLAGSTAFF AZ 86004-7377
Thomas Ichim director 211 E. OSBORN RD, PHOENIX AZ 85012
Creative Medical Health Inc. 10 percent owner 211 E. OSBORN RD, PHOENIX AZ 85012
Timothy Herbst 10 percent owner 2031 W. PEORIA AVE., SUITE 250, PHOENIX AZ 85029
Amit Nilkanth Patel director 1040 CHARTWELL CT., SALT LAKE CITY UT 84121
Donald Dickerson director, officer: CFO & Sr.VP 822 VERA STREET, SOLANA BEACH CA 92075
Steven L White director, officer: President,Secretary,Treasurer 386 NORTH 210 EAST, MAPLETON UT 84664

Creative Medical Technology Holdings (Creative Medical Technology Holdings) Headlines

From GuruFocus